Sensulin™ has developed a proprietary drug delivery platform, called Agglomerated Vesicle Technology (AVT). The technology is covered by one issued U.S. patent and one US/PCT patent application. This platform is based upon a series of liposomes that are linked by a stimulus-responsive molecule, which can be used to encapsulate a variety of drugs, that are triggered by a variety of stimuli.
Please see Dr. Annapragada’s peer-reviewed publications below, for more information on the system. If you are interested in testing our AVT delivery system, please contact Mike Moradi by filling out the contact us form or calling 1-650-479-6453.